VERACYTE, INC. Interest Expense
VERACYTE, INC. (VCYT) reported Interest Expense of $63.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-07-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2021-07-29
- VERACYTE, INC. interest expense for the quarter ending 2021-06-30 was $63.00K, a 3.08% decline year-over-year.
- VERACYTE, INC. interest expense for the quarter ending 2021-03-31 was $53.00K, a 3.64% decline year-over-year.
- VERACYTE, INC. interest expense for the quarter ending 2020-12-31 was $54.00K, a 33.33% decline year-over-year.
- VERACYTE, INC. interest expense for the quarter ending 2020-09-30 was $55.00K, a 5.17% decline year-over-year.
- VERACYTE, INC. interest expense for fiscal 2020 was $229.00K, a 66.17% decline from fiscal 2019.
- VERACYTE, INC. interest expense for fiscal 2019 was $677.00K, a 65.51% decline from fiscal 2018.
- VERACYTE, INC. interest expense for fiscal 2018 was $1.96M, a 60.27% decline from fiscal 2017.
- VERACYTE, INC. interest expense for fiscal 2017 was $4.94M, a 79.22% increase from fiscal 2016.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $63.00K 10-Q · filed 2021-07-29 | $116.00K 10-Q · filed 2021-07-29 | $170.00K derived: sum of 3 quarters · filed 2021-07-29 | $225.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | $53.00K 10-Q · filed 2021-05-10 | $107.00K derived: sum of 2 quarters · filed 2021-05-10 | $162.00K derived: sum of 3 quarters · filed 2021-05-10 | $227.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $109.00K derived: sum of 2 quarters · filed 2021-02-22 | $174.00K derived: sum of 3 quarters · filed 2021-07-29 | $229.00K 10-K · filed 2021-02-22 |
| 2020-09-30 | $55.00K 10-Q · filed 2020-11-02 | $120.00K derived: sum of 2 quarters · filed 2021-07-29 | $175.00K 10-Q · filed 2020-11-02 | $256.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-06-30 | $65.00K 10-Q · filed 2021-07-29 | $120.00K 10-Q · filed 2021-07-29 | $201.00K derived: sum of 3 quarters · filed 2021-07-29 | $259.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $55.00K 10-Q · filed 2021-05-10 | $136.00K derived: sum of 2 quarters · filed 2021-05-10 | $194.00K derived: sum of 3 quarters · filed 2021-05-10 | $429.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $139.00K derived: sum of 2 quarters · filed 2021-02-22 | $374.00K derived: sum of 3 quarters · filed 2021-02-22 | $677.00K 10-K · filed 2021-02-22 |
| 2019-09-30 | $58.00K 10-Q · filed 2020-11-02 | $293.00K derived: sum of 2 quarters · filed 2020-11-02 | $596.00K 10-Q · filed 2020-11-02 | $1.13M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $235.00K 10-Q · filed 2020-07-30 | $538.00K 10-Q · filed 2020-07-30 | $1.07M derived: sum of 3 quarters · filed 2021-02-22 | $1.57M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $303.00K 10-Q · filed 2020-05-06 | $839.00K derived: sum of 2 quarters · filed 2021-02-22 | $1.34M derived: sum of 3 quarters · filed 2021-02-22 | $1.82M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.03M derived: sum of 2 quarters · filed 2021-02-22 | $1.51M derived: sum of 3 quarters · filed 2021-02-22 | $1.96M 10-K · filed 2021-02-22 |
| 2018-09-30 | $498.00K 10-Q · filed 2019-10-22 | $979.00K derived: sum of 2 quarters · filed 2019-10-22 | $1.43M 10-Q · filed 2019-10-22 | $3.94M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $481.00K 10-Q · filed 2019-07-30 | $929.00K 10-Q · filed 2019-07-30 | $3.45M derived: sum of 3 quarters · filed 2020-02-25 | $4.26M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $448.00K 10-Q · filed 2019-04-30 | $2.97M derived: sum of 2 quarters · filed 2020-02-25 | $3.78M derived: sum of 3 quarters · filed 2020-02-25 | $4.59M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.33M derived: sum of 2 quarters · filed 2020-02-25 | $4.14M derived: sum of 3 quarters · filed 2020-02-25 | $4.94M 10-K · filed 2020-02-25 |
| 2017-09-30 | $815.00K 10-Q · filed 2018-10-29 | $1.62M derived: sum of 2 quarters · filed 2018-10-29 | $2.42M 10-Q · filed 2018-10-29 | $3.23M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $808.00K 10-Q · filed 2018-07-23 | $1.61M 10-Q · filed 2018-07-23 | $2.41M derived: sum of 3 quarters · filed 2019-02-25 | $3.21M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $800.00K 10-Q · filed 2018-05-01 | $1.61M derived: sum of 2 quarters · filed 2019-02-25 | $2.40M derived: sum of 3 quarters · filed 2019-02-25 | $3.19M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $806.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $1.60M derived: sum of 2 quarters · filed 2019-02-25 | $2.39M derived: sum of 3 quarters · filed 2019-02-25 | $2.76M 10-K · filed 2019-02-25 |
| 2016-09-30 | $799.00K 10-Q · filed 2017-11-07 | $1.58M derived: sum of 2 quarters · filed 2017-11-07 | $1.95M 10-Q · filed 2017-11-07 | $2.06M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $785.00K 10-Q · filed 2017-07-31 | $1.15M 10-Q · filed 2017-07-31 | $1.26M derived: sum of 3 quarters · filed 2018-02-27 | $1.35M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $367.00K 10-Q · filed 2017-05-03 | $476.00K derived: sum of 2 quarters · filed 2018-02-27 | $568.00K derived: sum of 3 quarters · filed 2018-02-27 | $658.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $201.00K derived: sum of 2 quarters · filed 2018-02-27 | $291.00K derived: sum of 3 quarters · filed 2018-02-27 | $378.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $92.00K 10-Q · filed 2016-11-03 | $182.00K derived: sum of 2 quarters · filed 2016-11-03 | $269.00K 10-Q · filed 2016-11-03 | $372.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $90.00K 10-Q · filed 2016-08-03 | $177.00K 10-Q · filed 2016-08-03 | $280.00K derived: sum of 3 quarters · filed 2017-03-01 | $394.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $89.00K 10-Q · filed 2016-05-05 | $190.00K derived: sum of 2 quarters · filed 2017-03-01 | $304.00K derived: sum of 3 quarters · filed 2017-03-01 | $417.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $215.00K derived: sum of 2 quarters · filed 2017-03-01 | $328.00K derived: sum of 3 quarters · filed 2017-03-01 | $439.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $114.00K 10-Q · filed 2015-11-05 | $227.00K derived: sum of 2 quarters · filed 2015-11-05 | $338.00K 10-Q · filed 2015-11-05 | $440.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $113.00K 10-Q · filed 2015-08-13 | $224.00K 10-Q · filed 2015-08-13 | $326.00K derived: sum of 3 quarters · filed 2016-03-14 | $452.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $111.00K 10-Q · filed 2015-05-15 | $213.00K derived: sum of 2 quarters · filed 2016-03-14 | $339.00K derived: sum of 3 quarters · filed 2016-03-14 | $344.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $228.00K derived: sum of 2 quarters · filed 2016-03-14 | $233.00K derived: sum of 3 quarters · filed 2016-03-14 | $233.00K 10-K · filed 2016-03-14 |
| 2013-09-30 | $126.00K 10-Q · filed 2014-11-13 | $131.00K derived: sum of 2 quarters · filed 2014-11-13 | $131.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $5.00K 10-Q · filed 2014-08-14 | $5.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |